Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
2
×
detroit top stories
eli lilly
fda
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
advaxis
aimmune therapeutics
alder biopharmaceutical
alder biopharmaceuticals
alexander hardy
allergan
american academy of neurology
amgen
andrew oxtoby
atogepant
babies
biohaven
bob azelby
What
big
2
×
approval
arguments
bio
bosley's
bosley’s
bridge
bucks
cas
ceo
class
commercialized
companies
competitors
crime
crispr
decades
departure
drug
drugs
editas
exit
fda
guiding
katrine
make
medicine
meeting
migraine
moves
neuro
new
oral
personnel
potential
roundup
surprising
therapies
week
won
Language
Current search:
fda
×
biotech
×
" detroit blog main "
×
big
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More